| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/14/1999 | CA2307560A1 System, method and composition for dialysis and shock treatment |
| 05/12/1999 | EP0915157A2 Method for the preparation of functional recombinant tissue factor |
| 05/12/1999 | EP0914432A2 Secreted proteins and polynucleotides encoding them |
| 05/12/1999 | EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914147A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions |
| 05/12/1999 | EP0914124A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 05/12/1999 | EP0914111A2 Method for the prevention and treatment of cachexia and anorexia |
| 05/12/1999 | EP0914110A1 Method of modulating microcirculation |
| 05/12/1999 | EP0914103A1 Treatment of a hemoglobinopathy |
| 05/12/1999 | EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof |
| 05/12/1999 | EP0739354B1 Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | CN1216544A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use |
| 05/11/1999 | US5902829 Administering prior to surgery a modulating mixture of l-arginine or a precursor thereof and a carrier; prevention of hypoperfusion-reperfsion injury and amelioration of hypoperfusion; substrate for nitic oxide synthetase; |
| 05/11/1999 | US5902812 Inhibitors of plasminogen activator inhibitor |
| 05/11/1999 | US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 05/11/1999 | US5902735 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for hirudin, hirudin obtained, and its pharmaceutical use |
| 05/11/1999 | CA2046632C Thrombolytic from vampire bat saliva |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999021830A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | WO1999021582A2 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/06/1999 | WO1999021559A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| 05/06/1999 | WO1999008729A9 Loading and release of water-insoluble drugs |
| 05/06/1999 | EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 05/06/1999 | EP0912735A2 Secreted proteins and polynucleotides encoding them |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0912613A1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912197A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 05/06/1999 | EP0912180A1 Heterocyclic compounds with thrombolytic activity and their use for treating thrombosis |
| 05/06/1999 | EP0912175A1 Fibrinogen receptor antagonists |
| 05/06/1999 | EP0688315B1 Pyrrolidine and oxazolidine derivatives, their preparation and their use as inhibitors of thrombocyte aggregation |
| 05/06/1999 | EP0624199B1 Methods for producing thrombin |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | CA2847985A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308443A1 Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307163A1 Process for stereoselective synthesis of prostacyclin derivatives |
| 05/06/1999 | CA2306790A1 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1216041A Carboxylic acid derivs, their production and use |
| 05/04/1999 | US5901069 System, method, and computer program product for at least partially automatically generating chemical compounds with desired properties from a list of potential chemical compounds to synthesize |
| 05/04/1999 | US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents |
| 05/04/1999 | US5900412 Percutaneous/transdermal delivery of ASA and antithrombotic therapies based thereon |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 04/29/1999 | WO1999020767A1 Modified vitamin k-dependent polypeptides |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020249A1 Solution for peritoneal dialysis and process for its manufacture |
| 04/29/1999 | WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 04/29/1999 | DE19746868A1 Use of tumour necrosis factor antagonists |
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910628A1 Inactivation resistant factor viii |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |
| 04/28/1999 | EP0910573A1 New amino acid derivatives and their use as thrombin inhibitors |
| 04/28/1999 | EP0910564A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215401A 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives endothelin antagonists |
| 04/28/1999 | CN1215338A Pharmaceutical combination containing a compound having angiotensin II and antagonisti activity |
| 04/28/1999 | CN1215054A Bychclic fibrinogen antagonists |
| 04/28/1999 | CN1043140C Hydroxymethyl furazane carboxylic acid derivatives and its preparation process and medicinal composition |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5897860 Hemostatic composition; treating ulcers, suturing blood vessels, treating hemophilia, inhibiting growth of microrganisms |
| 04/27/1999 | CA2087743C Pharmaceutical composition for inhibiting platelet aggregation |
| 04/27/1999 | CA2064585C Inhibition of tumor growth by blockade of the protein c system |
| 04/27/1999 | CA1340512C Expression of factor vii and ix activities in mammalian cells |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/22/1999 | WO1999019356A1 Trivalent thrombin inhibitor |
| 04/22/1999 | WO1999019320A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/22/1999 | WO1999018994A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999002565A3 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | WO1998043618A9 Use of cytoskeletal inhibitors for the prevention of restenosis |
| 04/22/1999 | DE19745712A1 New composition for treating sickle cell disease |
| 04/22/1999 | CA2306823A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 04/22/1999 | CA2306206A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | CA2305499A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0690671A4 Method and apparatus for encapsulation of biologically-active substances in cells |
| 04/21/1999 | CN1214734A SCF analog compositions and method |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999018090A1 An efficient method for the conversion of nitriles to amidines |
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1999018074A1 Novel lactam metalloprotease inhibitors |
| 04/15/1999 | WO1999017790A1 PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017775A1 QUINOLINE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 04/15/1999 | WO1999017762A1 Concentrate for medical solution and use thereof |
| 04/15/1999 | WO1999017742A2 Taste masked formulations |
| 04/15/1999 | WO1999017612A1 Serotonin containing formulation for oral administration and method of use |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |